Compare 10X Genomics Inc (TXG) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.51. The key difference: 10X Genomics Inc is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| TXG | USIG | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Fixed Income |
52-Week High | $45.80 | $52.69 |
52-Week Low | $11.34 | $50.50 |
Enterprise Value | $5.02B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
